Immunosuppressive therapy in patients with connective tissue disease‐associated pulmonary arterial hypertension: A systematic review-Reference-Cited by-同舟云学术

Immunosuppressive therapy in patients with connective tissue disease‐associated pulmonary arterial hypertension: A systematic review

Published:2022-06-14 Issue:9 Volume:25 Page:982-990
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J of Rheum Dis

Author:

Ding Yufang¹^ORCID,Qian Junyan¹,Zhang Shangzhu¹,Xu Dong¹^ORCID,Leng Xiaomei¹,Zhao Jiuliang¹,Wang Qian¹^ORCID,Zhang Wen¹^ORCID,Tian Xinping¹^ORCID,Li Mengtao¹,Zeng Xiaofeng¹

Affiliation:

1. Department of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC‐DID), State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences Beijing China

Funder

Beijing Municipal Science and Technology Commission

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.14368

Reference47 articles.

1. Pathogenesis of Pulmonary Arterial Hypertension

2. Pulmonary vascular remodeling in pulmonary hypertension

3. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension